Skip to main content

Advertisement

Table 3 Cox multivariate analysis for bRFS of patients with localized prostate cancer

From: Long-term outcome of a moderately hypofractionated, intensity-modulated radiotherapy approach using an endorectal balloon for patients with localized prostate cancer

Covariate b SE Wald P value Exp(b)
Gleason score 0.88 0.21 17.7 < 0.01 2.42 (1.60–3.66)
T stage 0.76 0.24 9.6 < 0.01 2.13 (1.32–3.44)
Pretreatment PSA level (mg/dL) 0.34 0.25 1.8 0.18 1.40 (0.85–2.31)
D’Amico risk category 0.05 0.51 0.01 0.92 1.05 (0.39–2.86)
ADT − 0.03 0.46 0.01 0.95 0.97 (0.39–2.40)
  1. b regression coefficient b, SE stand error of regression coefficient b, Wald Wald statistic (b/SE)2, Exp(b) exponentiation of the b coefficient